Tango Therapeutics, Inc. (TNGX) Earnings
|
Expand Research on TNGX
| Next EPS Date | 8/12/26 | EPS Growth Rate | +8.6% |
|---|---|---|---|
| Average EPS % Beat Rate | -23.5% | Revenue Growth Rate | -51.0% |
| Average % Move 1-Wk after EPS | +4.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.32 | N/A | N/A | $1.56M | N/A | N/A | N/A | ||
| 5/13/26 | Q126 | -$0.32 | -$0.31 | -$0.01 | N/A | $635.9K | N/A |  | | Details | |
| 3/5/26 |
Q425 | -$0.29 | -$0.32 | +$0.03 | N/A | $500.4K | N/A | | | Details | |
| 11/4/25 | Q325 | -$0.14 | -$0.07 | -$0.07 | $53.81M | $53.8M | N/A | | | Details | |
| 8/5/25 | Q225 | -$0.35 | -$0.35 | $0.00 | $3.18M | $6.42M | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.36 | -$0.36 | $0.00 | $5.4M | $6.73M | N/A | | | Details | |
| 3/31/25 |
Q424 | N/A | -$0.34 | N/A | N/A | $8.21M | N/A | N/A | N/A | ||
| 11/6/24 | Q324 | -$0.27 | -$0.37 | +$0.10 | $11.61M | $8.07M | N/A | | | Details |
